PDS Biotechnology (PDSB) earnings, Nov 13, 2026: EPS +42%, stock −11.0%
In brief
PDS Biotechnology reported on Nov 13, 2026. Earnings per share changed +42% year over year, 22.2% below the estimate; revenue 0%. The stock opened with a +1.0% gap and closed the day −11.0% (Nov 13, 2026). The stock is now 51.3% below its 52-week high, +3.3% over 12 months.
EPS vs estimate−22.2%
EPS, YoY+42%
Revenue, YoY0%
Gap · day+1.0% · −11.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 13, 2026 | +1.5% | +7.5% |
| Aug 13, 2026 | −1.4% | −1.1% |
| Nov 13, 2026 | +1.0% | −11.0% |
Next-quarter estimates, ratings and the PDSB chart are in the terminal.
Open the terminalFAQ
When is PDS Biotechnology's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did PDS Biotechnology stock react to the report?
Opening gap +1.0%, day's result −11.0%.
Did PDS Biotechnology's earnings grow?
Earnings per share rose 42% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.